Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Basis for Strain-Dependent Rat Aldehyde Dehydrogenase 1A7 (ALDH1A7) Gene Expression

Katerina Touloupi, Jenni Küblbeck, Angeliki Magklara, Ferdinand Molnár, Mika Reinisalo, Maria Konstandi, Paavo Honkakoski and Periklis Pappas
Molecular Pharmacology November 2019, 96 (5) 655-663; DOI: https://doi.org/10.1124/mol.119.117424
Katerina Touloupi
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenni Küblbeck
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jenni Küblbeck
Angeliki Magklara
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angeliki Magklara
Ferdinand Molnár
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ferdinand Molnár
Mika Reinisalo
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mika Reinisalo
Maria Konstandi
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Konstandi
Paavo Honkakoski
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paavo Honkakoski
  • For correspondence: phonka@email.unc.edu
Periklis Pappas
Departments of Pharmacology (K.T., M.K., P.P.) and Clinical Chemistry (A.M.), Faculty of Medicine, School of Health Sciences, University of Ioannina, and Department of Biomedical Research, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology (A.M.), Ioannina, Greece; School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland (J.K., F.M., M.R., P.H.);Department of Biology, School of Science and Technology, Nazarbayev University, Nur-Sultan City, Kazakhstan (F.M.); Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (P.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Periklis Pappas
  • For correspondence: ppappas@cc.uoi.gr
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Strain-dependent expression and inducibility of ALDH1A isoforms. Normalized expression of ALDH1A7 (A) and ALDH1A1 (B) mRNA in control, PB-, or PCN-treated RR and rr rat livers. Levels are expressed as scatter plots and means ± S.D. from four animals, each sample with two technical replicates. Cytosolic and total protein levels of ALDH1 protein (C) and activity (D) in control, PB-, or PCN-treated RR and rr rat livers. Statistically significant differences (P < 0.05) compared with the respective control group or between the strains are marked by * and # signs, respectively. The data in (A, B, and D) are also shown relative to the control RR values, set at 1.0, and expressed as means ± S.D. of -fold change below the x-axis.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Similar expression of CYP2Bs and NRs in both rat substrains. Normalized expression of CYP2B1 (A) and CYP3A23 (B) mRNA in control, PB-, or PCN-treated RR and rr rat livers. (C) Comparison of hepatic CAR and PXR mRNA expression between control rat strains. The ratio of target gene to β-actin mRNA expression (y-axis) are shown as scatter plots and means ± S.D. from four animals, each sample with two technical replicates. These normalized levels are also depicted as relative to the mean ± S.D. of the control RR strain, set at 1.0, and indicated below the x-axis. Statistically significant differences (P < 0.05) compared with the respective control group or between the strains are marked by * and # signs, respectively. (D) Expression of CAR and PXR proteins in control, PB- or PCN-treated RR and rr rat livers.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Strain-dependent activation of ALDH1A7 promoter constructs by NRs. Luciferase activity of the full-length RR-ALDH1A7 (gray columns) and rr-ALDH1A7 (black columns) constructs cotransfected with empty (−) or indicated CAR or PXR expression vectors (+), and treated with DMSO (ligand −) or selective CAR or PXR activators (ligand +). Positive control plasmids were PBREM-tk-luc for CAR and XREM-3A4-luc for PXR (white columns). Data are means ± S.D. from three independent transfections and expressed relative to the empty vector (set at 1.0). *Denotes a statistically significant difference from the empty vector at P < 0.05.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Basal and NR-elicited activation of proximal ALDH1A7 promoter constructs. (A) Basal luciferase reporter activity from RR-ALDH1A7 and rr-ALDH1A7 longer (−1571/+5 bp) and shorter (−461/+5 bp) promoter fragments. #Denotes a statistically significant different from the pGL3-Basic construct at P < 0.05; (B) NR-dependent luciferase activity from RR-ALDH1A7 and rr-ALDH1A7 longer and shorter promoter fragments in cotransfection assays with empty or indicated NR expression vectors. ns, no statistically significant differences between constructs with empty or NR expression vectors.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Polymerase II binding to RR-ALDH1A7 and rr-ALDH1A7 proximal promoters. Both strains were dosed with saline (C) or PB for 3 hours; liver nuclear fractions were isolated and crosslinked, and RNA polymerase-associated DNA was analyzed by ChIP assay as detailed in Materials and Methods. The amount of recovered DNA is shown relative to the negative control (nc) region (set at 1.0). Data are scatter plots from two independent experiments, each sample with two technical replicates.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    RXRα binding to putative CAR binding sites in the distal regions of RR-ALDH1A7 (A) and rr-ALDH1A7 (B) promoters. Both strains were dosed with saline (C) or PB for 3 hours, and liver nuclear fractions were isolated and crosslinked, and RXRα- associated DNA was analyzed by ChIP assay as detailed in Materials and Methods. The amount of recovered DNA is shown relative to the negative control region (set at 1.0). Data are scatter plots from two independent experiments, each sample with two technical replicates.

Additional Files

  • Figures
  • Data Supplement

    • Supplemental Data -

      Supplementary Table 1 - Primers for ALDH1A7 cloning.

      Supplementary Table 2 - Primers for ChIP assay.

      Supplementary Table 3 - Predicted transcription factor sites in the RR and rr ALDH1A7 upstream sequences.

      Supplementary Table 4 -  Predicted nuclear receptor binding elements in the RR and rr ALDH1A7 upstream sequences.

      Supplementary Table 5 - Group mean Ct values of -actin, ALDH and CYP mRNAs in the multiple dose study.

      Supplementary Figure 1 - Alignment of the ALDH1A7 promoters from the RR and rr strains.

      Supplementary Figure 2 -  Cytosolic and total ALDH1 protein levels in control, PB- and PCN-treated RR and rr rat livers.

      Supplementary Figure 3 - Total CAR and PXR protein levels in control, PB- and PCN-treated RR and rr rat livers.

      Supplementary Figure 4 - Time course of PB induction in RR and rr rats.

      Supplementary Figure 5 - Time course of PCN induction in RR and rr rats.

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 96 (5)
Molecular Pharmacology
Vol. 96, Issue 5
1 Nov 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Basis for Strain-Dependent Rat Aldehyde Dehydrogenase 1A7 (ALDH1A7) Gene Expression
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Strain-Dependent ALDH1A7 Expression in the Rat

Katerina Touloupi, Jenni Küblbeck, Angeliki Magklara, Ferdinand Molnár, Mika Reinisalo, Maria Konstandi, Paavo Honkakoski and Periklis Pappas
Molecular Pharmacology November 1, 2019, 96 (5) 655-663; DOI: https://doi.org/10.1124/mol.119.117424

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Strain-Dependent ALDH1A7 Expression in the Rat

Katerina Touloupi, Jenni Küblbeck, Angeliki Magklara, Ferdinand Molnár, Mika Reinisalo, Maria Konstandi, Paavo Honkakoski and Periklis Pappas
Molecular Pharmacology November 1, 2019, 96 (5) 655-663; DOI: https://doi.org/10.1124/mol.119.117424
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • P2X7 Positive Modulator Structure-Activity Relationship
  • Predicting Drug Interactions with ENT1 and ENT2
  • GABAAR Molecular Identity in Oligodendrocytes
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics